Clinical outcomes of the enrolled patients
| Clinical outcomes | Medical group (n=42) | Endovascular group (n=43) | p Value* |
|---|---|---|---|
| Primary endpoint | 4 (9.5%) | 4 (9.3%) | 1.000 |
| Within 30 days | 0 (0%) | 3 (7.0%) | 0.241 |
| Fatal stroke† | 2 (4.8%) | 1 (2.3%) | 0.616 |
| Secondary endpoint | 2 (4.8%) | 2 (4.7%) | 1.000 |
| Stroke in other territory | 2 (4.8%) | 0 | 0.241 |
| Mortality | 0 | 2 (4.7%)‡ | 0.494 |
*Fisher exact test.
†Fatal stroke was defined as showing a modified Rankin Scale score of ≥4 at the time of the event.
‡A result of pneumonia and malignancy. Not related to endovascular treatment.